Etravirine (Intelence, TMC 125)

Published February 12, 2008; Updated July 2018
Susa Coffey, MD
Selected Reference
6. Ruxrungtham K, Pedro RJ, Latiff GH, et al; TMC125-C227 Study Group. Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naive, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227. HIV Med. 2008 Nov;9(10):883-96.